Michał Kiełbus
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents 2
-
- Protein Degradation and Inhibitors 3
- CRISPR and Genetic Engineering 2
-
- Plant chemical constituents analysis 3
-
- Photoreceptor and optogenetics research 2
-
- Chronic Lymphocytic Leukemia Research 2
- Glioma Diagnosis and Treatment 2
-
- Antimicrobial Resistance in Staphylococcus 2
Michał Kiełbus
28 papers receiving 567 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Toxicology 26
- Cancer Research 102
- Drug Discovery 1
- Molecular Biology 347
- Applied Microbiology and Biotechnology 9
Countries citing papers authored by Michał Kiełbus
This map shows the geographic impact of Michał Kiełbus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michał Kiełbus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michał Kiełbus more than expected).
Fields of papers citing papers by Michał Kiełbus
This network shows the impact of papers produced by Michał Kiełbus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michał Kiełbus. The network helps show where Michał Kiełbus may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michał Kiełbus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | Estrogen Receptor Signaling in Breast Cancerbreakdown → | 2023 | 76 |
| 8 | 2023 | 1 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 3 | |
| 11 | 2020 | 22 | |
| 12 | 2019 | 2 | |
| 13 | 2019 | 6 | |
| 14 | 2018 | 12 | |
| 15 | 2018 | 22 | |
| 16 | 2016 | 29 | |
| 17 | 2015 | 175 | |
| 18 | 2015 | 13 | |
| 19 | 2014 | 17 | |
| 20 | 7-substituted coumarins inhibit proliferation and migration of laryngeal cancer cells in vitro. | 2013 | 39 |
About Michał Kiełbus
Michał Kiełbus is a scholar working on Toxicology, Genetics and Hematology, having authored 31 papers that have together received 578 indexed citations. Recurring topics across this work include Plant chemical constituents analysis (3 papers), Protein Degradation and Inhibitors (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Photoreceptor and optogenetics research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Glioma Diagnosis and Treatment (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Toxicology (26 citations), Cancer Research (102 citations) and Drug Discovery (1 citation). Michał Kiełbus has collaborated with scholars based in Poland, Finland and Belgium. Frequent co-authors include Andrzej Stepulak, Adolfo Rivero‐Müller, Sylwia Król, Magdalena Dmoszyńska‐Graniczka, Joanna Kałafut, Alicja Przybyszewska-Podstawka, Krzysztof Polberg, Aneta Grabarska, Jolanta Smok-Kalwat and Paulina Miziak.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.